Abstract
Deprescribing involves reducing or stopping medications that are causing more harm than good or are no longer needed. It is an important approach to managing polypharmacy, yet healthcare professionals identify many barriers. We present a proposed pre-licensure competency framework that describes essential knowledge, teaching strategies, and assessment protocols to promote interprofessional deprescribing skills. The framework considers how to involve patients and care partners in deprescribing decisions. An action plan and example curriculum mapping exercise are included to help educators assess their curricula, and select and implement these concepts and strategies within their programs to ensure learners graduate with competencies to manage increasingly complex medication regimens as people age.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Background: the Rationale for a Deprescribing Competency Framework
As the population ages, healthcare professionals will encounter older adults with multiple chronic conditions taking many medications, for whom the balance of potential benefit and harm from medications may shift over time. Decisions related to continuing, reducing, or stopping medications, especially in older adults, can be difficult. There is a growing need to standardize the teaching and assessment of deprescribing knowledge and skills to address these challenges.
In 2016, one-quarter of Canadian seniors were prescribed ten or more medications, with half treated with at least one medication on the American Geriatrics Society Beers Criteria® list of “potentially inappropriate medications” (PIMs) [1, 2]. The prevalence of PIMs and polypharmacy (use of unnecessary medications, or medications where harm outweighs benefit) [3, 4] has risen steadily internationally over the past two decades [5,6,7,8]. As the number of PIMs increases, so too does the risk of adverse drug events (ADEs) [9], drug-drug interactions [10], hospital admissions [9, 11, 12], and mortality [13, 14]. Medications may become potentially inappropriate when they are continued longer than intended (e.g., proton pump inhibitors, antidepressants) [15], or when many are used to treat multiple chronic conditions resulting in additive harmful effects [16,17,18], or when they are continued in the context of frailty [19,20,21], dementia [22], or end-of-life care [23, 24] when the beneficial effect is no longer evidence-based [25, 26], apparent, or aligned with the patient’s goals of care. Growing risk of medication harm is related to progressive functional decline and pharmacodynamic changes that, for example, increase sensitivity to cardiovascular medications, anticoagulants, opioids, antipsychotics, and benzodiazepines [27,28,29,30].
Deprescribing is the patient-centered, planned, and supervised process of dose reduction or stopping of a medication that may be causing harm or may no longer be providing benefit [31]. It is a fundamental component of appropriate prescribing which can improve quality of life and medication adherence while reducing ADEs, system cost, and patient expense [32,33,34]. Deprescribing, with appropriate monitoring, is safe [35], with non-randomized studies suggesting deprescribing can reduce mortality [36].
There is international agreement that problematic polypharmacy must be addressed and that deprescribing is a vital solution. The World Health Organization (WHO) Medication Without Harm – Global Patient Safety Challenge on Medication Safety, launched in 2017, aims to reduce severe, avoidable medication-related harm by 50% in 5 years. The WHO describes the importance of considering deprescribing in medication reviews and attending to deprescribing as robustly as prescribing [37]. Likewise, the Australian and Scottish governments and the Lown Institute in America have identified the importance of reducing polypharmacy and educating and training health professionals to reduce medication overload [38,39,40]. Since 2015, the Canadian Deprescribing Network has been working both nationally and provincially with the public, healthcare professionals, and policymakers to raise awareness about medication safety, deprescribing, and promoting increased access to safer pharmacologic and non-pharmacologic therapies [41, 42]. Other national and international deprescribing networks have also been launched to address the growing concerns regarding aging, polypharmacy, and medication-related harm [43,44,45].
It is well documented that a number of barriers to deprescribing exist [46,47,48,49,50,51]. Physicians, pharmacists, nurses, and other healthcare professionals have identified knowledge and skill deficits regarding polypharmacy management, PIM use, balancing medication benefits and harms, and difficulties recognizing ADEs and prescribing cascades. These and other deprescribing concepts are beginning to be taught in some undergraduate programs, but implementation is inconsistent and non-standardized; learners continue to express low confidence and self-efficacy for deprescribing [47, 52,53,54,55,56,57,58,59].
To prepare interdisciplinary teams to deprescribe, we must address these deficits by consistently teaching principles, knowledge, and skills required for effective evidence-based deprescribing. While physicians, pharmacists, and nurses prescribe, deprescribe, dispense, administer, and monitor medications, other healthcare professionals can also identify patients who may benefit from medication review, deprescribing, and non-pharmacological approaches to care [60,61,62,63,64,65,66,67]. Ideally, a structured, robust curriculum within each respective healthcare program should present prescribing principles and assessments to ensure the implementation of appropriate deprescribing practices.
Currently, deprescribing competencies are taught and assessed to varying degrees (or not at all) within healthcare curricula across Canada. A 2018 international symposium on deprescribing education [68] acknowledged that deprescribing skills are not consistently taught or assessed in many countries. Subsequently, members of the Canadian Deprescribing Network’s Healthcare Providers Education Committee, an interprofessional group, sought input from Canadian healthcare professional educators, deprescribing leaders, and clinicians involved in the care of older people. Through an iterative process involving literature review, consultation and several rounds of discussion and revision and group consensus, we developed this position paper to provide guidance on teaching and assessing deprescribing as part of a continuum of appropriate prescribing within an interprofessional context.
This paper targets educators in medicine, pharmacy, and nursing involved in the design and delivery of entry-to-practice (pre-licensure) programs and organizations that accredit these. It also supports the education of other healthcare professionals (e.g., physiotherapists, occupational therapists, dietitians, dentists, speech-language pathologists, social workers) who can identify medication safety concerns or adverse drug effects, and who may recommend non-pharmacological approaches that reduce reliance on medications [61].
The objective of this paper is to provide a deprescribing competency curriculum framework for medicine, nursing, and pharmacy entry-to-practice degree programs. To enable educators to systematically integrate and assess deprescribing knowledge into their teaching and clinical practices, we propose a draft competency framework, options for learning outcomes at various levels, teaching and assessment strategies, and a toolkit of practical resources for curricular and experiential learning. We anticipate that this work will be applicable internationally although it is written from a Canadian perspective. Much of the polypharmacy and deprescribing research and clinical practice initiatives emerge from work in geriatric medicine. Therefore, this paper focuses on deprescribing in the context of care of older people, though we encourage curriculum developers to consider components of the framework in relation to other populations. Ultimately, our goal is to have health professional educators use this framework to identify and implement opportunities for their students to attain competencies in deprescribing.
Proposed Deprescribing Competency Framework
Deprescribing should be aligned with good prescribing. Several Canadian regulatory bodies, educators, and researchers have adopted the Royal Pharmaceutical Society’s (RPS) Competency Framework for All Prescribers, which lists ten competencies for prescribing: six address consultation and patient-centered care and four relate to prescribing governance [69]. The Royal College of Physicians and Surgeons of Canada (RCPSC) developed competencies for prescribing in their Prescribing Safely Canada initiative, with ten competencies, seven of which relate to patient and caregiver, and three related to system issues, ethics, and practice reflections [70]. Our draft deprescribing competency framework aligns with the prescribing competencies from both the RPS and RCPSC.
To inform the framework, we began with the deprescribing process outlined by Reeve et al., expanding their five-step process to encompass seven general competencies [71]. These include gathering and interpreting a patient’s medication history and clinical information in the context of patient-specific factors, using tools that help identify PIMs, weighing the potential benefit and harm of continuing or deprescribing medications, using shared decision-making to make decisions about deprescribing, communicating deprescribing and monitoring plans, and monitoring progress and outcomes. The seven statements describe the general competencies for consideration by curriculum planners and are expanded upon in Table 1 [1, 69, 70, 72,73,74,75,76,77] with descriptions of the required knowledge and skills. We recognize that the competencies may need to be individualized for different programs, but importantly, they begin the conversation about how to integrate deprescribing competencies into healthcare professional education. We also recognize that many health professional programs are tightly scheduled, and it may seem challenging to determine if or how these competencies might be integrated in a busy program. To facilitate this process, we have included those RCPSC and RPS competencies that align with the deprescribing competencies in Table 1, supporting the approach to co-teach these concepts. We have also provided an example of a process that could be used to assess current curricula for consistencies and gaps (Appendix 1).
To make decisions about deprescribing, healthcare professionals must understand a patient’s medication experience. Medication reconciliation can identify medications without a clear/current indication. Explicit tools such as STOPP/START [73] and AGS Beers Criteria® [1] and implicit tools such as the Medication Appropriateness Index [75] can be used to identify potentially inappropriate or unnecessary medications. Reviewing the patient’s clinical conditions, functional status, and laboratory tests can guide decisions regarding medication choice, benefit/harms, dosing, interactions, and contraindications.
A shared decision-making process supports patient and healthcare professional discussions about the balance of potential benefit and harm for each medication [78]. This can elucidate medications that may no longer be appropriate and help prioritize these for deprescribing [79]. Healthcare professionals must be able to elicit patient values and beliefs about their health and their goals of care, and incorporate this information with their clinical knowledge of the medical conditions and medications and the context in which care is being delivered to inform priorities and plan for how deprescribing will take place [80].
Implementing deprescribing requires both technical knowledge and cognitive skills. These include understanding prescription changes, regulatory requirements, and communication/documentation skills. Cognitive skills include the ability to prioritize, think critically, use emotional intelligence for interactions with patients, and work within an interprofessional team.
The following competencies, to be applied in collaboration with the patient and/or their family/care partners, are proposed for deprescribing:
-
1.
Conduct a comprehensive patient medication history
-
2.
Interpret relevant information in the context of desired therapeutics outcomes and goals of care
-
3.
Identify medications that are no longer necessary, may have more harm than benefit, or are otherwise potentially inappropriate
-
4.
Assess the deprescribing potential of each medication by weighing benefits and harms
-
5.
Decide whether deprescribing a medication is appropriate using shared decision-making
-
6.
Design, document, and share a deprescribing and monitoring plan
-
7.
Monitor patient progress and provide support.
Consider Interprofessional Education
Based on their scope of practice, each entry-to-practice curriculum emphasizes different knowledge and skills related to medication use. All learners must have the requisite competencies related to health and evidence-informed practice and demonstrate the ability to develop a therapeutic relationship with the patient, engage them in their care, and work interprofessionally within their scope of practice.
Healthcare professionals in medicine, pharmacy, and nursing identify that they have a clear responsibility in medication management [61]. This includes identifying opportunities for deprescribing, engaging in shared decision-making, implementing the deprescribing plan, and following up on the deprescribing process.
Effective deprescribing leverages each healthcare professional’s strengths and unique perspective on patient care. Teaching deprescribing provides an opportunity for interprofessional education demonstrating how, for example, physicians, pharmacists, nurses, dentists, dieticians, physiotherapists, social workers, and others, can collaborate with patients and family/care partners. It is important to understand how an interprofessional team can function within various healthcare settings to leverage each professional’s expertise and scope of practice to improve medication use and safety.
Education Strategies
Deprescribing can be included early, midway, and later within programs. To understand the prescribing-deprescribing continuum, key concepts should be introduced early and built upon throughout the curriculum in a sequential manner. The competencies (Table 1) in this document focus on the knowledge and skills that learners completing their entry-to-practice degrees should be able to perform successfully. The learning outcomes (Table 2) are more specific and measurable and can be integrated into specific lesson plans or course syllabi. The expected level of competency for deprescribing activities may vary and should be determined by the health professional program, for example, whether a specific competency should be taught at an advanced or intermediate level, depending on the role of that health professional in medication management.
Deprescribing content can be taught as a standalone concept/module/course or progressively integrated into various courses throughout the program and included within experiential education. Standalone content may be appropriate for curricula where medication management is not a focus but where learners would benefit from understanding how some patient symptoms may be related to medications and may resolve with deprescribing. In such instances, highlighting their contribution toward reducing medication harm and supporting non-drug interventions is important.
Implementing effective deprescribing requires the application of knowledge regarding biological, pharmaceutical, and social sciences and a broad understanding of medication use behaviors, medication processes, pharmacokinetics, pharmacodynamics, team dynamics, shared decision-making, regulations, and policies. As polypharmacy is highly prevalent in older adults, much of our knowledge about deprescribing is informed by this population. As such, it is logical to include geriatrics courses that teach deprescribing; however, as we have outlined, principles should be introduced early on and carried throughout the curriculum.
Table 2 provides details, where we have applied models for learning frameworks and curriculum design [81, 82] to propose learning outcomes at different levels, examples of teaching and learning activities, and examples of assessment strategies. Ensuring learners have numerous, scaffolded, thoughtful learning and assessment activities throughout their programs, with meaningful interprofessional touchpoints, will support the development of competency in deprescribing.
Introductory/Early Learner
All healthcare professional learners begin to develop professional identity through understanding their scope of practice. At this stage, they require an understanding of the epidemiology of common health conditions and how such conditions may be caused or exacerbated by medications.
Medicine, pharmacy, and nursing programs should introduce learners to patient care and medication use processes, including how decisions related to prescribing and deprescribing are made. Such concepts should be taught in the context of effective communication within a shared decision-making framework. Learners must be able to gather information related to medication use and identify medications that may be inappropriate.
Mid-level Learner
All healthcare professional learners should be introduced to principles of geriatric medicine and made aware of common geriatric syndromes and medication-related problems, including drug interactions and adherence challenges. It is essential to advocate for a patient-centered approach, including the importance of including family/care partners in decision-making.
Approaches to interprofessional practice should be included in all curricula. Using the Canadian Interprofessional Health Collaborative (CIHC) Interprofessional Framework [83] and the domains of interprofessional communication, patient- and family-centered care should be introduced, emphasizing how this can support discussions regarding medication use.
Learners in medicine, pharmacy, and nursing should have specific curriculum requirements relating to geriatrics including common medication-related problems and physiological changes that affect medications with aging. They should be able to elicit a patient’s goals of care and determine if they align with their medications. Education should build on introductory learning to include the application of tools to identify polypharmacy, PIMs, and resources/tools to guide medication decision-making. Learners should be able to describe the deprescribing process, evidence related to both benefits and harms of medications, and evidence supporting deprescribing when available. Discussions of ethical challenges relating to medication problems in older adults, including the ethics of gaps in evidence, should be introduced. Learners should be able to apply deprescribing concepts to a simulated case of a patient with minimal disease burden/complexity.
Advanced Learner
All learners should be able to describe why and how older adults and other groups may be more vulnerable to medication problems and develop an understanding of how to provide care for those with late-stage chronic disease, terminal disease, dementia, and frailty, and those at the end-of-life. Additionally, learners should understand how care is provided in various settings (e.g., long-term care, acute care, outpatient, primary care) and the implications of deprescribing in these contexts, including unique system barriers, processes, and patient needs within different settings.
Medicine, pharmacy and nursing learners should be able to critically assess the levels of evidence, validity, strengths, and weaknesses of various tools used to identify PIMs and deprescribe medications, and determine the appropriate situations for the tools’ application. Learners should be able to prioritize medications for deprescribing and develop and implement a care plan that includes monitoring and support. Learners should be able to approach deprescribing given an integrated case study involving an older adult with complex multimorbid conditions. Complexity factors may also include ethical concerns, family dynamics, cultural differences, special or vulnerable populations. The curriculum should guide learners on how best to advocate for appropriate deprescribing, especially in older adults, and to understand safe medication practices.
Teaching and Assessment Strategies
Each healthcare profession has a unique culture and context for curriculum delivery and assessment, and each program may have different access to resources.
General guidelines for teaching deprescribing include:
-
Introduce deprescribing concepts early and emphasize that deprescribing is a continuum of prescribing
-
Provide education throughout all years of the program using progressively complex cases to enable learners to develop knowledge and skills related to medications and deprescribing
-
Increase the complexity of deprescribing scenarios by introducing different healthcare settings, family/care partners, team members, ethical considerations, and clinical characteristics
-
Structure deprescribing discussions in relation to all therapeutic areas and within curriculum relating to the patient’s social and health system context
-
Plan and integrate deprescribing concepts across interprofessional education programs
-
Incorporate teaching and learning strategies such as didactic, active learning, simulation, and experiential education
General guidelines for the assessment of deprescribing include:
-
Provide learners with both formative and summative feedback regarding deprescribing practice cases and assignments
-
Assess foundational concepts through multiple choice questions or short answers
-
Consider a range of approaches and decisions regarding deprescribing that are supported with rationale and development of care plans
-
Employ Objective Structured Clinical Examinations (OSCE) and Team OSCEs (TOSCE) to assess the application of basic and complex knowledge at different points in the program, from early to advanced levels
-
Integrate deprescribing concepts that can be assessed in other related courses that include communication activities, application of ethical principles, or assessment of evidence
-
Include specific objectives related to prescribing and deprescribing in experiential education/practicum and ensure assessment is conducted by preceptors (e.g., appropriately weighing of potential benefit and harm, communication, documentation, follow-up)
-
Ensure feedback from multiple sources, including patients and family/care partners, simulation facilitators, professors, near peers (same year, same program), senior peers (higher year, same program), and interprofessional team peers
A Call to Action
Deprescribing is best accomplished within an interprofessional practice that is patient-centered and informed by shared decision-making. Based on the seven deprescribing competencies outlined, educators should identify learning objectives to be attained through both uni- and inter-professional education. The specific knowledge and skills taught within programs will be dependent on the perceived gap between the suggested competencies and performance of graduates from the program.
Curricular leaders, national health professional faculty associations, and accrediting bodies must take the following steps, within suggested timeframes, to ensure that learners in medicine, pharmacy, and nursing attain the required competencies in deprescribing and that all healthcare professionals are able to recommend interventions, including non-pharmacological management, that reduce reliance on medications:
In the next year:
-
Examine what needs to happen within your profession, your program, and across interprofessional curricula to ensure graduates are trained to undertake or support deprescribing in their practice
In the next 2 years:
-
Map the curriculum to determine where, when, and how deprescribing competencies are included in current programming, including how they are taught and assessed and identify areas for inclusion
-
Develop a plan to address curricular gaps
-
Create opportunities within curricula to implement deprescribing competencies and determine how these will be taught and assessed
-
Utilize practical tools (Table 3) throughout the curriculum
In the next 4–6 years:
-
Evaluate the core deprescribing competencies of graduates to determine the effectiveness of curricular changes
Annually:
-
Share learnings and outputs (e.g. curricular innovations, continuous professional development opportunities, prescribing and deprescribing competency frameworks) with the Canadian Deprescribing Network (info@deprescribingnetworks.ca) to facilitate sharing, networking and collaboration across Canada.
Conclusion
Integrating deprescribing competencies in healthcare curricula requires an intentional and structured approach across all years of the program, focusing on interprofessional collaboration. Learning activities should be active and practical, progressing from early to advanced learner skills and include integration of deprescribing during experiential education. As appropriate, the guidelines for curriculum design and learner assessments in deprescribing, emphasized within a geriatric context, can be integrated throughout all therapeutic content/courses. The process of preparing healthcare professionals to be confident deprescribers relies on a solid foundation within the pre-licensure curriculum. Building this foundation is essential to ensure healthcare professionals are able to deprescribe safely to minimize the personal and societal costs of medication-related harm.
Availability of data and materials
Not applicable.
References
American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society. updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674–94. https://doi.org/10.1111/jgs.15767.
Canadian Institute for Health Information. Drug use among seniors in Canada, 2016. CIHI. 2018. https://secure.cihi.ca/free_products/drug-use-among-seniors-2016-en-web.pdf. Accessed 20 Dec 2021.
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230. https://doi.org/10.1186/s12877-017-0621-2.
Sirois C, Domingues NS, Laroche M-L, Zongo A, Lunghi C, Guénette L, et al. Polypharmacy definitions for multimorbid older adults need stronger foundations to guide research, clinical practice and public health. Pharmacy (Basel). 2019;7:126. https://doi.org/10.3390/PHARMACY7030126.
Nishtala PS, Salahudeen MS. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005–2013. Gerontology. 2015;61:195–202. https://doi.org/10.1159/000368191.
Zhang N, Sundquist J, Sundquist K, Ji J. An increasing trend in the prevalence of polypharmacy in Sweden: a nationwide register-based study. Front Pharmacol. 2020;11:326. https://doi.org/10.3389/fphar.2020.00326.
Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314:1818–31. https://doi.org/10.1001/JAMA.2015.13766.
Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13:1–10. https://doi.org/10.1186/S12916-015-0322-7/TABLES/4.
Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19:901–10. https://doi.org/10.1002/PDS.1984.
Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther. 2007;45:643–53. https://doi.org/10.5414/CPP45643.
Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol. 2014;77:1073–82. https://doi.org/10.1111/BCP.12292.
Lu WH, Wen YW, Chen LK, Hsiao FY. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. Can Med Assoc J. 2015;187:E130–7. https://doi.org/10.1503/CMAJ.141219.
Dedhiya SD, Hancock E, Craig BA, Doebbeling CC, Thomas J. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2010;8:562–70. https://doi.org/10.1016/S1543-5946(10)80005-4.
Chrischilles EA, VanGilder R, Wright K, Kelly M, Wallace RB. Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults. J Am Geriatr Soc. 2009;57:1000–6. https://doi.org/10.1111/J.1532-5415.2009.02269.X.
Mangin D, Lawson J, Cuppage J, Shaw E, Ivanyi K, Davis A, et al. Legacy drug-prescribing patterns in primary care. The Annals of Family Medicine. 2018;16:515–20. https://doi.org/10.1370/afm.2315.
Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51. https://doi.org/10.1186/1477-7525-2-51.
Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract. 2012;62:e821–6. https://doi.org/10.3399/bjgp12X659295.
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10:430–9. https://doi.org/10.1016/j.arr.2011.03.003.
Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124:1045–60. https://doi.org/10.1161/CIRCRESAHA.118.313236.
Gill SS. All, some or none? Statin prescribing for frail older adults. CMAJ. 2019;191:E30–1. https://doi.org/10.1503/cmaj.181671.
Strain WD, Down S, Brown P, Puttanna A, Sinclair A. Diabetes and frailty: an expert consensus statement on the management of older adults with type 2 diabetes. Diabetes Ther. 2021;12:1227–47. https://doi.org/10.1007/s13300-021-01035-9.
Parsons C. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem. Ther Adv Drug Saf. 2017;8:31–46. https://doi.org/10.1177/2042098616670798.
McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage. 2016;51:178-183.e2. https://doi.org/10.1016/j.jpainsymman.2015.09.003.
Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605–9. https://doi.org/10.1001/archinte.166.6.605.
Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26:793–890. https://doi.org/10.1007/s11606-010-1629-x.
Konrat C, Boutron I, Trinquart L, Auleley GR, Ricordeau P, Ravaud P. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One. 2012;7:e33559. https://doi.org/10.1371/journal.pone.0033559.
Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clin Geriatr Med. 2012;28:273–86. https://doi.org/10.1016/j.cger.2012.01.007.
le Couteur DG, Everitt A, Lebel M. The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology. 2002;48:121–7.
Catananti C, Liperoti R, Settanni S, Lattanzio F, Bernabei R, Fialova D, et al. Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharmacol Ther. 2009;86:307–10. https://doi.org/10.1038/clpt.2009.89.
Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29:453–62. https://doi.org/10.2165/11631760-000000000-00000.
Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. PLoS One. 2016;11. https://doi.org/10.1371/journal.pone.0161248.
Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3–11. https://doi.org/10.1016/J.EJIM.2016.12.021.
Moriarty F, Cahir C, Bennett K, Fahey T. Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models. BMJ Open. 2019;9:3021832. https://doi.org/10.1136/bmjopen-2018-021832.
Sanyal C, Turner JP, Martin P, Tannenbaum C. Cost-effectiveness of pharmacist-led deprescribing of NSAIDs in community-dwelling older adults. J Am Geriatr Soc. 2020;68:1090–7. https://doi.org/10.1111/JGS.16388.
Thio SL, Nam J, van Driel ML, Dirven T, Blom JW. Effects of discontinuation of chronic medication in primary care: A systematic review of deprescribing trials. Br J Gen Pract. 2018;68: e663. https://doi.org/10.3399/BJGP18X699041.
Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82:583. https://doi.org/10.1111/BCP.12975.
World Health Organization. Medication without harm - global patient safety challenge on medication safety. 2017;1–16. https://www.who.int/initiatives/medication-without-harm. Accessed 15 Nov 2022.
Australian Commission on Safety and Quality in Health Care. Quality use of medicines and medicines safety (10th National Priority). Discussion paper for public consultation – Phase 1: Aged care. ACSQHC. Published 2020. https://www.safetyandquality.gov.au/sites/default/files/2020-09/quality_use_of_medicines_and_medicines_safety_-_discussion_paper.pdf. Accessed 20 Dec 2021.
Garber J. Eliminating medication overload: a national action plan. Working group on medication overload. Brookline, MA: The Lown Institute. 2020:1–94. https://lowninstitute.org/reports/eliminating-medication-overload-a-national-action-plan/. Accessed 20 Dec 2021.
Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing, 3rd Edition. NHS Scotland. 2018:1–40. Accessed 20 Dec 2021.
Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, et al. An ecological approach to reducing potentially inappropriate medication use: Canadian Deprescribing Network. Can J Aging. 2017;36:97–107. https://doi.org/10.1017/S0714980816000702.
Turner JP, Currie J, Trimble J, Tannenbaum C. Strategies to promote public engagement around deprescribing: Ther Adv Drug Saf. 2018;9:653–65. https://doi.org/10.1177/2042098618794165.
Australian Deprescribing Network. https://www.australiandeprescribingnetwork.com.au/. Accessed 9 Nov 2022.
US Deprescribing Research Network. https://deprescribingresearch.org/. Accessed 9 Nov 2022.
Looking for deprescribing networks? - Deprescribing.org. https://deprescribing.org/looking-for-deprescribing-networks/. Accessed 9 Nov 2022.
Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs & Aging 2013 30:10. 2013;30:793–807. https://doi.org/10.1007/S40266-013-0106-8.
Farrell B, Richardson L, Raman-Wilms L, de Launay D, Alsabbagh MW, Conklin J. Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines. Res Social Adm Pharm. 2018;14:18–25. https://doi.org/10.1016/j.sapharm.2017.01.003.
Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4: e006544. https://doi.org/10.1136/BMJOPEN-2014-006544.
Doherty AJ, Boland P, Reed J, Clegg AJ, Stephani A-M, Williams NH, et al. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open. 2020;4. https://doi.org/10.3399/BJGPOPEN20X101096.
Bokhof B, Junius-Walker U. Reducing polypharmacy from the perspectives of general practitioners and older patients: a synthesis of qualitative studies. Drugs Aging. 2016;33:249–66. https://doi.org/10.1007/S40266-016-0354-5.
Gillespie RJ, Harrison L, Mullan J. Deprescribing medications for older adults in the primary care context: a mixed studies review. Health Sci Rep. 2018;1: e45. https://doi.org/10.1002/HSR2.45.
Turner JP, Edwards S, Stanners M, Shakib S, Bell JS. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open. 2016;6: e009781. https://doi.org/10.1136/BMJOPEN-2015-009781.
Sun W, Tahsin F, Barakat-Haddad C, Turner JP, Haughian CR, Abbass-Dick J. Exploration of home care nurse’s experiences in deprescribing of medications: a qualitative descriptive study. BMJ Open. 2019;9: e025606. https://doi.org/10.1136/BMJOPEN-2018-025606.
Zou D, Tannenbaum C. Educational needs, practice patterns and quality indicators to improve geriatric pharmacy care. Canadian Pharmacists Journal. 2014;147:110. https://doi.org/10.1177/1715163514521378.
Poots AJ, Jubraj B, Ward E, Wycoco A, Barnett N. Education around medication review and deprescribing: a survey of medical and pharmacy students’ perspectives. Ther Adv Drug Saf. 2020;11. https://doi.org/10.1177/2042098620909610.
Clark CM, Hejna M, Shao E, Maerten-Rivera JL, Monte SV, Wahler RG. Knowledge and attitudes of student pharmacists regarding polypharmacy and deprescribing: a cross-sectional study. Pharmacy (Basel). 2020;8:220. https://doi.org/10.3390/PHARMACY8040220.
Ng B, Duong M, Lo S, Le Couteur D, Hilmer S. Deprescribing perceptions and practice reported by multidisciplinary hospital clinicians after, and by medical students before and after, viewing an e-learning module. Res Social Adm Pharm. 2021;17:1997–2005. https://doi.org/10.1016/J.SAPHARM.2021.03.002.
Zimmerman KM, Bell CA, Donohoe KL, Salgado TM. Medicine, pharmacy and nursing trainees’ perceptions of curriculum preparation to deprescribe and interprofessional roles in the deprescribing process. Gerontol Geriatr Educ. 2020;41:63–84. https://doi.org/10.1080/02701960.2019.1661840.
Barnett NL, Jubraj B, Grant D, Reddy B, Stevenson JM. Medication review, polypharmacy and deprescribing: results of a pilot scoping exercise in undergraduate and postgraduate education. Pharmacy Education. 2021;21:126–32. https://doi.org/10.46542/PE.2021.211.126132
Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA. 2018;320:1889. https://doi.org/10.1001/JAMA.2018.16131.
Farrell B, Thompson W, Black CD, Archibald D, Raman-Wilms L, Grassau P, et al. Health care providers’ roles and responsibilities in management of polypharmacy: results of a modified Delphi: Can Pharm J. 2018;151:395–407. https://doi.org/10.1177/1715163518804276.
Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Am Fam Physician. 2019;99:7–9.
Frank C. Deprescribing: a new word to guide medication review. CMAJ. 2014;186:407. https://doi.org/10.1503/CMAJ.131568.
Scott I, Le Couteur D. Physicians need to take the lead in deprescribing. Intern Med J. 2015;45:352–6. https://doi.org/10.1111/IMJ.12693.
Farrell B, Clarkin C, Conklin J, Dolovich L, Irving H, McCarthy L, et al. Community pharmacists as catalysts for deprescribing: an exploratory study using quality improvement processes. Canadian Pharmacists Journal. 2020;153:37. https://doi.org/10.1177/1715163519882969.
Naughton C, Hayes N. Deprescribing in older adults: a new concept for nurses in administering medicines and as prescribers of medicine. Eur J Hosp Pharm. 2017;24:47–50. https://doi.org/10.1136/ejhpharm-2016-000908.
Sun W, Grabkowski M, Zou P, Ashtarieh B. The development of a deprescribing competency framework in geriatric nursing education. West J Nurs Res. 2021;43. https://doi.org/10.1177/01939459211023805.
Raman-Wilms L, Farrell B, Sadowski C, Austin Z. Deprescribing: an educational imperative. Res Social Adm Pharm. 2019;15:790–5. https://doi.org/10.1016/j.sapharm.2018.08.011.
Royal Pharmaceutical Society. A competency framework for all prescribers. 2021:1–24. https://www.rpharms.com/resources/frameworks/prescribing-competency-framework/competency-framework Accessed 31 Mar 2022.
Brien S, Chan M-K, Grill A, Holbrook A, Landriault A, Matlow A. The prescribing safely Canada physician prescribing competencies. Royal College of Physicians and Surgeons of Canada. 2018:1–5. https://rcportal.royalcollege.ca/mssites/prescribingsafely/EN/PSCCOMP2018.pdf Accessed 31 Mar 2022.
Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78:738–47. https://doi.org/10.1111/BCP.12386.
Canadian Pharmacists Association, Canadian Society of Hospital Pharmacists, Institute for Safe Medication Practices Canada, University of Toronto Faculty of Pharmacy. Medication Reconciliation (MedRec). ISMP Canada. 2012. https://www.ismp-Canada.org/medrec/. Accessed 18 Aug 2021.
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing. 2014;44:213–8. https://doi.org/10.1093/ageing/afu145.
Lisibach A, Benelli V, Ceppi MG, Waldner-Knogler K, Csajka C, Lutters M. Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review. Eur J Clin Pharmacol. 2021;77:147–62. https://doi.org/10.1007/S00228-020-02994-X.
Hanlon JT, Schmader KE. The medication appropriateness index at 20: Where it started, where it has been, and where it may be going. Drugs Aging. 2013;30:893–900. https://doi.org/10.1007/S40266-013-0118-4.
Lavan AH, Gallagher P, Parsons C, O’Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46:600–7. https://doi.org/10.1093/AGEING/AFX005.
Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648–54. https://doi.org/10.1001/ARCHINTERNMED.2010.355.
Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353. https://doi.org/10.1136/BMJ.I2893.
Weir KR, Bonner C, McCaffery K, Naganathan V, Carter SM, Rigby D, et al. Pharmacists and patients sharing decisions about medicines: development and feasibility of a conversation guide. Res Social Adm Pharm. 2019;15:682–90. https://doi.org/10.1016/J.SAPHARM.2018.08.009.
Weir KR, Naganathan V, Carter SM, Tam CWM, McCaffery K, Bonner C, et al. The role of older patients’ goals in GP decision-making about medicines: a qualitative study. BMC Fam Pract. 2021;22:1–12. https://doi.org/10.1186/S12875-020-01347-Y/TABLES/3.
UCD Teaching and Learning. Using Biggs’ model of constructive alignment in curriculum design. http://www.ucdoer.ie/index.php/Using_Biggs%27_Model_of_Constructive_Alignment_in_Curriculum_Design/Introduction. Accessed 9 Sep 2021.
CAST. Universal design for learning guidelines. 2018. https://udlguidelines.cast.org/. Accessed 9 Sep 2021.
Accreditation of Interprofessional Health Education Initiative. Canadian Interprofessional Health Collaborative (CIHC) Framework. 2010; February:1–32. http://www.cihc.ca/files/CIHC_IPCompetencies_Feb1210.pdf. Accessed 25 Nov 2021.
Acknowledgements
The lead authors wish to thank all members of the Canadian Deprescribing Network Healthcare Providers Education Committee for generously donating their time and expertise in contributing to the direction, content, and approval of this manuscript to promote uptake of a deprescribing competency framework for healthcare professional learners. Each of these individuals has also worked tirelessly to promote deprescribing in clinical practice, education, and research.
Funding
None for writing; open-access fee sponsored by an operating grant from the Canadian Institutes of Health Research (201303MOP-299872-KTR-CFCL-108262).
Author information
Authors and Affiliations
Contributions
All authors contributed to the conception and design of the manuscript. Barbara Farrell, Lalitha Raman-Wilms, and Cheryl Sadowski led the literature review and developed the initial manuscript draft; Laurie Mallery contributed to the competency, knowledge, and skills table; Justin Turner and Camille Gagnon provided a critical review of the manuscript; all committee members reviewed and commented on successive drafts; all authors and committee members read and approved the final manuscript and agreed to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethical Approval
Not required.
Other Disclosures
J.P. Turner receives funding from a MITACS Elevate Postdoctoral Fellowship (IT11649) and a Fonds de recherche du Québec – Santé chercheur boursier Junior 1 (298843).
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Farrell, B., Raman-Wilms, L., Sadowski, C.A. et al. A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing. Med.Sci.Educ. 33, 551–567 (2023). https://doi.org/10.1007/s40670-022-01704-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40670-022-01704-9